Westminster Health Forum: Next steps for Advanced Therapies in the UK

This conference will consider the future for advanced therapies in the UK. Delegates will examine key issues for research and regulation - as the UK responds to the COVID-19 pandemic and at the same time prepares for possible regulatory and market changes at the end of the transition period.

Matthew Durdy, Chief Executive Officer

Keynote: Advanced therapies: power and potential for the UK


The discussion at a glance:

  • the impact of COVID-19 - and how the sector is adapting to meet needs and changes in the supply chain, logistics and regulatory landscape
  • infrastructure and the workforce - priorities for supporting the development of advanced therapies - and the role and potential of the Advanced Therapy Treatment Centres (ATTC) network
  • the regulatory and approval process - key issues and the impact of possible regulatory divergence from the EU as the transition moves towards its conclusion
  • innovation and research - what more support is needed, across the UK, and what is being done to provide certainty over long term funding
  • improving adoption of advanced therapies in the NHS - and patient involvement
  • the accelerated trial and approval processes in place during the pandemic - what can be learned going forward for supporting advanced therapies to market
  • making the UK a global hub - prospects and policy priorities

More information and view the full agenda here

Discover who we are